Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liver metastases license neutrophils through IL-1 to potentiate cancer progression.
Pearson AN, Waninger J, Huber AK, Holcomb EA, James JG, Kyi J, Elaimy AL, Wang Z, Lasse Opsahl EL, SenGupta S, Elliott DA, Choi E, Zhang Q, Morgan MA, Chang DT, Lawrence TS, Courtney A, Shah YM, Knight JS, Pasca di Magliano M, Yoo S, Crivelli S, Parent CA, Ramnath N, Bryant AK, Zou W, Green MD. Pearson AN, et al. Among authors: knight js. Cancer Immunol Res. 2025 Sep 4. doi: 10.1158/2326-6066.CIR-24-1074. Online ahead of print. Cancer Immunol Res. 2025. PMID: 40906822
Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling.
Shi H, Liang W, Yang Z, Hoy CK, Wang Q, Ding Z, Pan H, Shi Y, Shen Y, Sarosh C, Yalavarthi S, Kapoor P, Hudgins L, Vance CE, Wasikowski R, Figueroa-Parra G, Tambralli A, Madison JA, Tsoi LC, Gudjonsson JE, Yang C, Duarte-García A, Zuo Y, Billi AC, Tsou PS, Knight JS. Shi H, et al. Among authors: knight js. Circulation. 2025 Aug 29. doi: 10.1161/CIRCULATIONAHA.125.073552. Online ahead of print. Circulation. 2025. PMID: 40878676
A Disrupted Adenosinergic Axis Facilitates Platelet Activation in APS: Exploring a Novel Therapeutic Target.
NaveenKumar SK, Newman TG, Fonseca BM, Yalavarthi S, Flores Nascimento MC, Sabb K, Kmetova K, Chong E, Sugur K, Ranger CH, Tompkins MP, Sarosh C, Madison JA, Tambralli A, Schaefer JK, Holinstat M, Zuo Y, Knight JS. NaveenKumar SK, et al. Among authors: knight js. Blood Adv. 2025 Jul 24:bloodadvances.2025016162. doi: 10.1182/bloodadvances.2025016162. Online ahead of print. Blood Adv. 2025. PMID: 40705954
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial.
Branch DW, Kim MY, Guerra MM, Worden J, Laskin CA, DeSancho MT, Landres IV, Knight JS, Slosberg HS, Minett M, Salmon JE. Branch DW, et al. Among authors: knight js. Ann Rheum Dis. 2025 Jun;84(6):1011-1022. doi: 10.1016/j.ard.2025.02.012. Epub 2025 Apr 10. Ann Rheum Dis. 2025. PMID: 40483169 Clinical Trial.
243 results